Skip to main content
Top
Published in: Respiratory Research 1/2011

Open Access 01-12-2011 | Research

Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients

Authors: Panagiota Tzani, Marina Aiello, Davide Elia, Luca Boracchia, Emilio Marangio, Dario Olivieri, Enrico Clini, Alfredo Chetta

Published in: Respiratory Research | Issue 1/2011

Login to get access

Abstract

Background

Pulmonary hyperinflation has the potential for significant adverse effects on cardiovascular function in COPD. The aim of this study was to investigate the relationship between dynamic hyperinflation and cardiovascular response to maximal exercise in COPD patients.

Methods

We studied 48 patients (16F; age 68 yrs ± 8; BMI 26 ± 4) with COPD. All patients performed spirometry, plethysmography, lung diffusion capacity for carbon monoxide (TLco) measurement, and symptom-limited cardiopulmonary exercise test (CPET). The end-expiratory lung volume (EELV) was evaluated during the CPET. Cardiovascular response was assessed by change during exercise in oxygen pulse (ΔO2Pulse) and double product, i.e. the product of systolic blood pressure and heart rate (DP reserve), and by the oxygen uptake efficiency slope (OUES), i.e. the relation between oxygen uptake and ventilation.

Results

Patients with a peak exercise EELV (%TLC) ≥ 75% had a significantly lower resting FEV1/VC, FEF50/FIF50 ratio and IC/TLC ratio, when compared to patients with a peak exercise EELV (%TLC) < 75%. Dynamic hyperinflation was strictly associated to a poor cardiovascular response to exercise: EELV (%TLC) showed a negative correlation with ΔO2Pulse (r = - 0.476, p = 0.001), OUES (r = - 0.452, p = 0.001) and DP reserve (r = - 0.425, p = 0.004). Furthermore, according to the ROC curve method, ΔO2Pulse and DP reserve cut-off points which maximized sensitivity and specificity, with respect to a EELV (% TLC) value ≥ 75% as a threshold value, were ≤ 5.5 mL/bpm (0.640 sensitivity and 0.696 specificity) and ≤ 10,000 Hg · bpm (0.720 sensitivity and 0.783 specificity), respectively.

Conclusion

The present study shows that COPD patients with dynamic hyperinflation have a poor cardiovascular response to exercise. This finding supports the view that in COPD patients, dynamic hyperinflation may affect exercise performance not only by affecting ventilation, but also cardiac function.
Appendix
Available only for authorised users
Literature
1.
go back to reference O'Donnell DE: Dynamic hyperinflation and its clinical implication in COPD. Rev Mal Respir. 2008, 25: 1305-18. 10.1016/S0761-8425(08)75094-0.CrossRefPubMed O'Donnell DE: Dynamic hyperinflation and its clinical implication in COPD. Rev Mal Respir. 2008, 25: 1305-18. 10.1016/S0761-8425(08)75094-0.CrossRefPubMed
2.
go back to reference O'Donnell DE: Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006, 3: 180-84. 10.1513/pats.200508-093DO.CrossRefPubMed O'Donnell DE: Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006, 3: 180-84. 10.1513/pats.200508-093DO.CrossRefPubMed
3.
go back to reference Jörgesen K, Müller MF, Nel J, Upton RN, Houltz E, Ricksten SE: Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema. Chest. 2007, 131: 1050-57. 10.1378/chest.06-2245.CrossRef Jörgesen K, Müller MF, Nel J, Upton RN, Houltz E, Ricksten SE: Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema. Chest. 2007, 131: 1050-57. 10.1378/chest.06-2245.CrossRef
4.
go back to reference Barr GR, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JA, Shahar E, Smith LJ, Watsom KE: Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med. 2010, 362: 217-27. 10.1056/NEJMoa0808836.CrossRefPubMedPubMedCentral Barr GR, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JA, Shahar E, Smith LJ, Watsom KE: Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med. 2010, 362: 217-27. 10.1056/NEJMoa0808836.CrossRefPubMedPubMedCentral
5.
go back to reference Vassaux C, Torre-Bouscoulet L, Zeineldine S, Cortopassi F, Paz-Diaz H, Celli BR, Pinto-Plata VM: Effects of hypeinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J. 2008, 32: 1275-82. 10.1183/09031936.00151707.CrossRefPubMed Vassaux C, Torre-Bouscoulet L, Zeineldine S, Cortopassi F, Paz-Diaz H, Celli BR, Pinto-Plata VM: Effects of hypeinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J. 2008, 32: 1275-82. 10.1183/09031936.00151707.CrossRefPubMed
6.
go back to reference Task Force of the Italian Working Group on Cardiac Rehabilitation Prevention; Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology, Piepoli MF, Corrà U, Agostoni PG, Belardinelli R, Cohen-Solal A, Hambrecht R, Vanhees L: Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part I: definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2006, 13: 150-64.CrossRef Task Force of the Italian Working Group on Cardiac Rehabilitation Prevention; Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology, Piepoli MF, Corrà U, Agostoni PG, Belardinelli R, Cohen-Solal A, Hambrecht R, Vanhees L: Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part I: definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2006, 13: 150-64.CrossRef
7.
go back to reference Le V-V, Mitiku T, Sungar G, Myers J, Froelicher V: The blood pressure response to dynamic exercise testing: a systematic review. Prog Cardiovasc Dis. 2008, 5: 135-60.CrossRef Le V-V, Mitiku T, Sungar G, Myers J, Froelicher V: The blood pressure response to dynamic exercise testing: a systematic review. Prog Cardiovasc Dis. 2008, 5: 135-60.CrossRef
8.
go back to reference Baba R, Nagashima M, Goto M, Nagano Y, Yokota M, Tauchi N, Nishibata K: Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol. 1996, 28: 1567-72. 10.1016/S0735-1097(96)00412-3.CrossRefPubMed Baba R, Nagashima M, Goto M, Nagano Y, Yokota M, Tauchi N, Nishibata K: Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol. 1996, 28: 1567-72. 10.1016/S0735-1097(96)00412-3.CrossRefPubMed
9.
go back to reference Pauwels RA, Buist AS, Calverley PM, Jenkins , GOLD Scientific Committee: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001, 163: 1256-76.CrossRefPubMed Pauwels RA, Buist AS, Calverley PM, Jenkins , GOLD Scientific Committee: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001, 163: 1256-76.CrossRefPubMed
10.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: ATS/ERS Task Force Standardisation of spirometry. Eur Respir J. 2005, 26: 319-38. 10.1183/09031936.05.00034805.CrossRefPubMed Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: ATS/ERS Task Force Standardisation of spirometry. Eur Respir J. 2005, 26: 319-38. 10.1183/09031936.05.00034805.CrossRefPubMed
11.
go back to reference Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G: Standardisation of the measurement of lung volumes. Eur Respir J. 2005, 26: 511-22. 10.1183/09031936.05.00035005.CrossRefPubMed Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G: Standardisation of the measurement of lung volumes. Eur Respir J. 2005, 26: 511-22. 10.1183/09031936.05.00035005.CrossRefPubMed
12.
go back to reference Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J: Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005, 6: 720-35.CrossRef Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J: Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005, 6: 720-35.CrossRef
13.
go back to reference Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993, 6: 5-40.CrossRef Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993, 6: 5-40.CrossRef
14.
go back to reference Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC: Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993, 6: 41-52.CrossRef Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC: Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993, 6: 41-52.CrossRef
15.
go back to reference ATS/ACCP: Statement on Cardiopulmonary Exercise Testing. Am J Respir Crit Care Med. 2003, 167: 211-277.CrossRef ATS/ACCP: Statement on Cardiopulmonary Exercise Testing. Am J Respir Crit Care Med. 2003, 167: 211-277.CrossRef
16.
go back to reference Wasserman K, Hansen JE: Sue DY Normal values. Principles of Exercise Testing & Interpretation. 1994, Lippincott Williams & Wilkins. Philadelphia US, 143-162. Wasserman K, Hansen JE: Sue DY Normal values. Principles of Exercise Testing & Interpretation. 1994, Lippincott Williams & Wilkins. Philadelphia US, 143-162.
17.
go back to reference Stubbing DG, Pengelly LD, Morse JL, Jones NL: Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol. 1980, 49: 511-515.PubMed Stubbing DG, Pengelly LD, Morse JL, Jones NL: Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol. 1980, 49: 511-515.PubMed
18.
go back to reference Gobel FL, Nordstrom LA, Nelson RR, Jorgensen CR, Wang Y: The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation. 1978, 57: 549-56.CrossRefPubMed Gobel FL, Nordstrom LA, Nelson RR, Jorgensen CR, Wang Y: The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation. 1978, 57: 549-56.CrossRefPubMed
19.
go back to reference Brooks SM: Surveillance for respiratory hazards. ATS News. 1982, 8: 12-16. Brooks SM: Surveillance for respiratory hazards. ATS News. 1982, 8: 12-16.
20.
go back to reference Tzani P, Piepoli MF, Longo F, Aiello M, Serra W, Maurizio AR, Olivieri D, Chetta A: Resting lung function in the assesment of the exercise capacity in patients with chronic heart failure. Am J Med Sci. 2010, 339: 210-215. 10.1097/MAJ.0b013e3181c78540.CrossRefPubMed Tzani P, Piepoli MF, Longo F, Aiello M, Serra W, Maurizio AR, Olivieri D, Chetta A: Resting lung function in the assesment of the exercise capacity in patients with chronic heart failure. Am J Med Sci. 2010, 339: 210-215. 10.1097/MAJ.0b013e3181c78540.CrossRefPubMed
21.
go back to reference Zweig MH, Campell G: Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993, 39: 561-77.PubMed Zweig MH, Campell G: Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993, 39: 561-77.PubMed
22.
go back to reference O'Donnell DE, Revill SM, Webb KA: Dynamic Hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001, 164: 770-77.CrossRefPubMed O'Donnell DE, Revill SM, Webb KA: Dynamic Hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001, 164: 770-77.CrossRefPubMed
23.
go back to reference Cerveri I, Dore R, Corsico A, Zoia MC, Pellegrino R, Brusasco V, Pozzi E: Assessment of emphysema in COPD. A functional and radiologic study. Chest. 2004, 125: 1714-18. 10.1378/chest.125.5.1714.CrossRefPubMed Cerveri I, Dore R, Corsico A, Zoia MC, Pellegrino R, Brusasco V, Pozzi E: Assessment of emphysema in COPD. A functional and radiologic study. Chest. 2004, 125: 1714-18. 10.1378/chest.125.5.1714.CrossRefPubMed
24.
go back to reference Puente-Maestu L, Garcia de Pedro J, Martinez-Abad Y, Ruíz de Oña JM, Llorente D, Cubillo JM: Dyspnea, ventilatory pattern, and changes in dynamic hyperinflation related to the intensity of constant work rate exercise in COPD. Chest. 2005, 128: 651-56. 10.1378/chest.128.2.651.CrossRefPubMed Puente-Maestu L, Garcia de Pedro J, Martinez-Abad Y, Ruíz de Oña JM, Llorente D, Cubillo JM: Dyspnea, ventilatory pattern, and changes in dynamic hyperinflation related to the intensity of constant work rate exercise in COPD. Chest. 2005, 128: 651-56. 10.1378/chest.128.2.651.CrossRefPubMed
25.
go back to reference Watz H, Waschki B, Meyer T, Kretshmar G, Kirsten A, Claussen M, Magnussen H: Decreasing Cardiac Chamber Sizes and Associated Heart Dysfunction in COPD. Role of Hyperinflation. Chest. 2010, 138 (1): 32-38.CrossRefPubMed Watz H, Waschki B, Meyer T, Kretshmar G, Kirsten A, Claussen M, Magnussen H: Decreasing Cardiac Chamber Sizes and Associated Heart Dysfunction in COPD. Role of Hyperinflation. Chest. 2010, 138 (1): 32-38.CrossRefPubMed
26.
go back to reference Butler J, Schrijen F, Henriquez A, Pow JM, Albert RK: Cause of the Raised Wedge Pressure on Exercise in Chronic Obstructive Pulmonary Disease. Am Rev Respir Dis. 1988, 138: 350-354.CrossRefPubMed Butler J, Schrijen F, Henriquez A, Pow JM, Albert RK: Cause of the Raised Wedge Pressure on Exercise in Chronic Obstructive Pulmonary Disease. Am Rev Respir Dis. 1988, 138: 350-354.CrossRefPubMed
27.
go back to reference Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H: Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity. Am J Respir Crit Care Med. 2008, 177: 743-751. 10.1164/rccm.200707-1011OC.CrossRefPubMed Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H: Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity. Am J Respir Crit Care Med. 2008, 177: 743-751. 10.1164/rccm.200707-1011OC.CrossRefPubMed
28.
go back to reference Whipp BJ, Higgenbotham MB, Cobb FC: Estimating exercise stroke volume from asymptotic oxygen pulse in humans. J Appl Physiol. 1996, 81: 2674-2679.PubMed Whipp BJ, Higgenbotham MB, Cobb FC: Estimating exercise stroke volume from asymptotic oxygen pulse in humans. J Appl Physiol. 1996, 81: 2674-2679.PubMed
29.
go back to reference Sala E, Roca J, Marrades RM, Gonzalez De Suso JM, Moreno A, Barberá JA, Nadal J, de Jover L, Rodriguez-Roisin R, Wagner PD: Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999, 159: 1726-1734.CrossRefPubMed Sala E, Roca J, Marrades RM, Gonzalez De Suso JM, Moreno A, Barberá JA, Nadal J, de Jover L, Rodriguez-Roisin R, Wagner PD: Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999, 159: 1726-1734.CrossRefPubMed
30.
go back to reference Oelberg DA, Kacmarek RM, Pappagianopoulos PP, Ginns LC, Systrom DM: Ventilatory and cardiovascular responses to inspired He-O2 during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998, 158: 1876-1882.CrossRefPubMed Oelberg DA, Kacmarek RM, Pappagianopoulos PP, Ginns LC, Systrom DM: Ventilatory and cardiovascular responses to inspired He-O2 during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998, 158: 1876-1882.CrossRefPubMed
31.
go back to reference Montes de Oca M, Rassulo J, Celli BE: Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med. 1996, 154: 1284-89.CrossRefPubMed Montes de Oca M, Rassulo J, Celli BE: Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med. 1996, 154: 1284-89.CrossRefPubMed
32.
go back to reference Nelson RR, Gobel FL, Jorgensen CR, Wang K, Wang Y, Taylor HL: Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulaion. 1974, 50: 1179-1189.CrossRef Nelson RR, Gobel FL, Jorgensen CR, Wang K, Wang Y, Taylor HL: Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulaion. 1974, 50: 1179-1189.CrossRef
33.
go back to reference Hollenberg M, Tager IB: Oxygen uptake efficiency slope: an index of exercise performance and cardiopulmonary reserve requiring only submaximal exercise. J AM Coll Cardiol. 2000, 36: 194-201. 10.1016/S0735-1097(00)00691-4.CrossRefPubMed Hollenberg M, Tager IB: Oxygen uptake efficiency slope: an index of exercise performance and cardiopulmonary reserve requiring only submaximal exercise. J AM Coll Cardiol. 2000, 36: 194-201. 10.1016/S0735-1097(00)00691-4.CrossRefPubMed
Metadata
Title
Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients
Authors
Panagiota Tzani
Marina Aiello
Davide Elia
Luca Boracchia
Emilio Marangio
Dario Olivieri
Enrico Clini
Alfredo Chetta
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2011
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-12-150

Other articles of this Issue 1/2011

Respiratory Research 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine